In most cancers, mutations of TP53 (the gene encoding the p53 tumor suppressor) or the loss of function of p53 are frequent, which result in low p21 levels because the transcription of the gene encoding p21 is dependent on p53 (reviewed in [43,63]). The gene discussed is CDKN1A; the disease is cancer.